Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 10 of 2537

TitleReference numberPublishedLast updated
Epcoritamab for treating relapsed or refractory follicular lymphoma after 2 or more lines of systemic treatmentTA1139
Pegzilarginase for treating arginase-1 deficiency in people 2 years and overHST35
Durvalumab with gemcitabine and cisplatin for neoadjuvant treatment then alone for adjuvant treatment of muscle-invasive bladder cancerTA1138
Rare diseasesQS214
Blood transfusionQS138
Molnupiravir for treating COVID-19TA1056
Hypertension in adults: diagnosis and managementNG136
Blood transfusionNG24
Nirmatrelvir plus ritonavir and tocilizumab for treating COVID-19TA878
Bevacizumab (originator and biosimilars) with fluoropyrimidine-based chemotherapy for metastatic colorectal cancerTA1136

Results per page

  1. 10
  2. 25
  3. 50
  4. All